Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09594-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Ubaid Tariq und 6 weiteren Autor:innen. Beteiligte Einrichtung: Non-communicable Disease Group, Translational Health Science and Technology Institute (THSTI), Faridabad, Haryana, 121001, India. Hauptthemen laut MEDLINE: NAV1.5 Voltage-Gated Sodium Channel, Cardiomegaly, Isoproterenol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Translational Health Science and Technology Institute (THSTI), India.
Abstract (Originalsprache)
SCN5A mutations have been reported to cause various cardiomyopathies in humans. Most of the SCN5A mutations causes loss of function and thereby, alters the overall cellular function. Therefore, to understand the loss of SCN5A function in cardiomyocytes, we have knocked down the SCN5A gene (SCN5A-KD) in H9c2 cells and explored the cell phenotype and molecular behaviors in the presence and absence of isoproterenol (ISO), an adrenergic receptor agonist that induces cardiac hypertrophy. Expression of several genes related to hypertrophy, inflammation, fibrosis, and energy metabolism pathways were evaluated. It was found that the mRNA expression of hypertrophy-related gene, brain (B-type) natriuretic peptide (BNP) was significantly increased in SCN5A-KD cells as compared to 'control' H9c2 cells. There was a further increase in the mRNA expressions of BNP and βMHC in SCN5A-KD cells after ISO treatment compared to their respective controls. Pro-inflammatory cytokine, tumor necrosis factor-alpha expression was significantly increased in 'SCN5A-KD' H9c2 cells. Further, metabolism-related genes like glucose transporter type 4, cluster of differentiation 36, peroxisome proliferator-activated receptor alpha, and peroxisome proliferator-activated receptor-gamma were significantly elevated in the SCN5A-KD cells as compared to the control cells. Upregulation of these metabolic genes is associated with increased ATP production. The study revealed that SCN5A knock-down causes alteration of gene expression related to cardiac hypertrophy, inflammation, and energy metabolism pathways, which may promote cardiac remodelling and cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Non-communicable Disease Group, Translational Health Science and Technology Institute (THSTI), Faridabad, Haryana, 121001, India.
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, 781101, India.
- Department of Cardiac Electrophysiology, Adult Cardiology, Toronto General Hospital, Toronto, ON, Canada.
- Non-communicable Disease Group, Translational Health Science and Technology Institute (THSTI), Faridabad, Haryana, 121001, India. sanjay@niperguwahati.in.
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, 781101, India. sanjay@niperguwahati.in.
Förderung
- Translational Health Science and Technology Institute (THSTI), India
Zitieren
APA
Tariq, U., Sarkar, S., Malladi, N., Kumar, R., Bugga, P., Chakraborty, P., & Banerjee, S. K. (2024). Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09594-3
Vancouver
Tariq U, Sarkar S, Malladi N, Kumar R, Bugga P, Chakraborty P, et al. Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09594-3
BibTeX
@article{Tariq2024,
author = {Tariq, Ubaid and Sarkar, Soumalya and Malladi, Navya and Kumar, Roshan and Bugga, Paramesha and Chakraborty, Praloy and Banerjee, Sanjay K},
title = {Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09594-3}
}
EUVIMED